Anastellin, the angiostatic fibronectin peptide, is a selective inhibitor of lysophospholipid signaling.

Ambesi, Anthony

Anastellin, the angiostatic fibronectin peptide, is a selective inhibitor of lysophospholipid signaling. [electronic resource] - Molecular cancer research : MCR Feb 2009 - 255-65 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural

1541-7786

10.1158/1541-7786.MCR-08-0195 doi


Angiogenesis Inhibitors--pharmacology
Angiostatic Proteins--pharmacology
Cell Movement
Cells, Cultured
Endothelium, Vascular--cytology
ErbB Receptors--genetics
Extracellular Signal-Regulated MAP Kinases--metabolism
Fibronectins--pharmacology
GTP-Binding Protein alpha Subunits, Gi-Go--metabolism
Humans
Immunoblotting
Immunoprecipitation
Lysophospholipids--antagonists & inhibitors
Microcirculation--physiology
Peptide Fragments--pharmacology
Phosphatidylinositol 3-Kinases--metabolism
Proto-Oncogene Proteins c-akt--metabolism
Receptors, G-Protein-Coupled--metabolism
Receptors, Vascular Endothelial Growth Factor--genetics
S Phase--drug effects
Signal Transduction--drug effects
Skin--blood supply
rho-Associated Kinases--metabolism